Matched-pair comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in patients with primary and biochemical recurrent prostate cancer

被引：0
|
作者：
Rauscher, I. [1 ]
Kroenke, M. [1 ]
Wurzer, A. [2 ]
Wester, H. [2 ]
Weber, W. [1 ]
Eiber, M. [1 ]
机构：
[1] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Munich, Germany
[2] Tech Univ Munich, Dept Pharmaceut Radiochem, Klinikum Rechts Isar, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-332
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [31] Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies
    Huo, Huasong
    Shen, Shurui
    He, Ding
    Liu, Bin
    Yang, Fuwei
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 16 - 24
  • [32] Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT
    Pernthaler, Birgit
    Nazerani Hooshmand, Tina
    Igrec, Jasminka
    Kvaternik, Herbert
    Aigner, Reingard M.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : E231 - E232
  • [33] Comparative diagnostic performance of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in detecting biochemical recurrent bone metastasis in prostate cancer: a systematic review and meta-analysis
    Wen, Xin
    Jiang, Cheng-Yi
    Jiang, Xu
    Chen, Yan
    Li, Meng
    ACTA RADIOLOGICA, 2025,
  • [34] 68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer—a modified protocol compared with the common protocol
    Fabian Haupt
    Lotte Dijkstra
    Ian Alberts
    Christos Sachpekidis
    Viktor Fech
    Silvan Boxler
    Tobias Gross
    Tim Holland-Letz
    Helle D. Zacho
    Uwe Haberkorn
    Kambiz Rahbar
    Axel Rominger
    Ali Afshar-Oromieh
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 624 - 631
  • [35] The additional value of 18F-FDG PET/CT compared to 68Ga-PSMA-11 PET/CT in initial diagnosed prostate cancer patients
    Wang, Yining
    Liu, Jianjun
    Chen, Ruohua
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [36] 68Ga-PSMA-11 and 18F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate
    Qiu, Shuang
    Dong, Aisheng
    Zhu, Yan
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (09) : 836 - 838
  • [37] Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer
    Inaki, Anri
    Mizokami, Atsushi
    Wakabayashi, Hiroshi
    Izumi, Kouji
    Kadono, Yoshifumi
    Toyama, Tadashi
    Takahara, Shizuko
    Murayama, Toshinori
    Kinuya, Seigo
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (08) : 587 - 595
  • [38] Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
    Chandekar, Kunal Ramesh
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : E1 - E8
  • [39] The value of 68Ga-PSMA-11 PET/CT in patients with prostate cancer and inconclusive standard imaging at primary staging
    Nalliah, Surenth
    Zacho, Helle D.
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (10) : 1092 - 1098
  • [40] 68Ga-PSMA-11 PET/CT in the evaluation of bone metastases in prostate cancer
    Sachpekidis, C.
    Baeumer, P.
    Hadaschik, B. A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S402 - S403
12345